This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Nicox S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Corinna Galli - Innovator in Ophthalmic Compositions
Introduction
Corinna Galli is an accomplished inventor based in Marcallo Con Casone, Italy. She is currently associated with Nicox S.a., where she focuses on developing innovative solutions for ocular health. Although she has not yet been granted any patents, her work in the field of ophthalmology is noteworthy.
Latest Patent Applications
Corinna Galli's recent patent application is titled "Compositions for the Treatment of Glaucoma and Ocular Hypertension." This invention relates to ophthalmic compositions that combine a nitric oxide releasing phosphodiesterase type 5 inhibitor (NO-PDE5 inhibitor) with a prostaglandin analog. The application outlines the use of these compositions for treating various forms of glaucoma and ocular hypertension, as well as other eye diseases associated with elevated intraocular pressure. The NO-PDE5 inhibitors mentioned include specific compounds designed to enhance therapeutic efficacy. The prostaglandin analogs selected for this application include well-known agents such as latanoprost, bimatoprost, travoprost, and tafluprost.
Conclusion
Corinna Galli's contributions to the field of ophthalmology through her innovative patent application demonstrate her commitment to advancing treatments for eye conditions. Her work has the potential to significantly impact the management of glaucoma and ocular hypertension.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile